Annexon (ANNX) Cash & Equivalents (2019 - 2026)

Annexon's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $175.2 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 78.5% year-over-year to $175.2 million; the TTM figure through Mar 2026 stood at $175.2 million (up 78.5% YoY), while the FY2025 annual figure was $160.0 million, up 216.72% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $175.2 million, up from $160.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $226.1 million in Q4 2023, with the low at $583000.0 in Q1 2022.
• The 5-year median for Cash & Equivalents is $139.4 million (2025), against an average of $131.0 million.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents sank 99.72% in 2022, then soared 24797.43% in 2023.
• Annexon's Cash & Equivalents stood at $141.1 million in 2022, then jumped by 60.33% to $226.1 million in 2023, then plunged by 77.66% to $50.5 million in 2024, then soared by 216.72% to $160.0 million in 2025, then climbed by 9.48% to $175.2 million in 2026.
• Business Quant data shows ANNX's Cash & Equivalents at $175.2 million in Q1 2026, $160.0 million in Q4 2025, and $139.4 million in Q3 2025.